Your browser doesn't support javascript.
loading
Cost-effectiveness of raltegravir in antiretroviral treatment-experienced HIV-1-infected patients in Switzerland.
Elbasha, E E; Szucs, T; Chaudhary, M A; Kumar, Ritesh N; Roediger, A; Cook, J R; Opravil, M.
Affiliation
  • Elbasha EE; Merck Research Laboratories, North Wales, Pennsylvania, USA.
HIV Clin Trials ; 10(4): 233-53, 2009.
Article in En | MEDLINE | ID: mdl-19723611

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidinones / HIV Infections / HIV-1 / Models, Economic / HIV Integrase Inhibitors Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: HIV Clin Trials Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) / TERAPEUTICA Year: 2009 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrrolidinones / HIV Infections / HIV-1 / Models, Economic / HIV Integrase Inhibitors Type of study: Clinical_trials / Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: HIV Clin Trials Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) / TERAPEUTICA Year: 2009 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido